Studies indicate that insulin signaling is impaired in the pathogenesis of PCOS, potentially due to disruptions in arginine and proline metabolism, leading to nitric oxide production that affects the IRS-1-PI3K/Akt signaling pathway. This evidence concerns the gene INS and polycystic ovary syndrome.